FindTrial
Sign In

Cervical transforaminal injection for the treatment of cervical radiculopathy under the guidance of ultrasound and radiography

Cervical transforaminal injection for the treatment of cervical radiculopathy under the guidance of ultrasound and radiography

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052149
Enrollment
Unknown
Registered
2021-10-20
Start date
2021-10-25
Completion date
Unknown
Last updated
2022-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cervical radiculopathy

Interventions

Experimental group1:ultrasound-guided cervical transforaminal block
Experimental group2:C-arm-guided cervical transforaminal block
Experimental group3:CT-guided cervical transforaminal block

Sponsors

Capital Medical University Affiliated Bejing Shijitan Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: 1. Patients with cervical radiculopathy with symptoms of upper extremity radiation radiculopathy; 2. CT or MRI examination is consistent with symptoms; 3. Conservative treatment such as oral drugs is not effective; 4. NRS score >= 4 points; 5. Aged >=18 years old and voluntarily participated in this study and received follow-up.

Exclusion criteria

Exclusion criteria: 1. Severe heart and lung disease; 2. Coagulation disorders; 3. Systemic infection or skin infection at the puncture site; 4. History of cervical spine surgery; 5. Abnormal mental behavior; 6. Breastfeeding and pregnant women.

Design outcomes

Primary

MeasureTime frame
the excellent rate of contrast distribution;—

Secondary

MeasureTime frame
puncture time;side effects;Pain Numerical Score;—

Countries

China

Contacts

Public ContactLi Juanhong

Capital Medical University Affiliated Bejing Shijitan Hospital

lijh@bjsjth.cn+86 15210301184

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026